Does Smith & Nephew (LON:SN.) Have A Healthy Balance Sheet?
Dec 15
Have your own idea? Try our Stock Screener
U.K. (FTSE) Healthcare Sector Analysis
UpdatedDec 17, 2024
DataAggregated Company Financials
Companies92
- 7D-2.3%
- 3M-12.9%
- 1Y-1.9%
- YTD-5.2%
Over the last 7 days, the Healthcare industry has dropped 2.3%, driven by declines in AstraZeneca and GSK of 1.7% and 4.6%, respectively. On the other hand Oxford Nanopore Technologies is actually up 9.5%. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 20% per annum.
Sector Valuation and Performance
Has the U.K. Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 17 Dec 2024 | UK£246.8b | UK£85.5b | UK£7.6b | 29.6x | 32.5x | 2.9x |
| Thu, 14 Nov 2024 | UK£242.7b | UK£85.4b | UK£7.6b | 25.1x | 32x | 2.8x |
| Sat, 12 Oct 2024 | UK£273.8b | UK£82.6b | UK£8.9b | 28.6x | 30.8x | 3.3x |
| Mon, 09 Sep 2024 | UK£295.7b | UK£82.1b | UK£8.8b | 32.8x | 33.4x | 3.6x |
| Wed, 07 Aug 2024 | UK£286.0b | UK£83.6b | UK£9.0b | 32.9x | 31.8x | 3.4x |
| Fri, 05 Jul 2024 | UK£279.5b | UK£81.5b | UK£9.4b | 30.4x | 29.8x | 3.4x |
| Sun, 02 Jun 2024 | UK£291.8b | UK£81.6b | UK£9.4b | 31.5x | 31.1x | 3.6x |
| Tue, 30 Apr 2024 | UK£284.9b | UK£81.9b | UK£9.9b | 31.8x | 28.7x | 3.5x |
| Thu, 28 Mar 2024 | UK£269.7b | UK£81.0b | UK£9.6b | 34.3x | 28x | 3.3x |
| Sat, 24 Feb 2024 | UK£260.8b | UK£80.5b | UK£9.4b | 38.5x | 27.6x | 3.2x |
| Mon, 22 Jan 2024 | UK£272.9b | UK£84.0b | UK£10.6b | 38.8x | 25.7x | 3.2x |
| Wed, 20 Dec 2023 | UK£264.8b | UK£83.8b | UK£10.6b | 40.4x | 24.9x | 3.2x |
| Fri, 17 Nov 2023 | UK£258.5b | UK£85.1b | UK£10.8b | 41.4x | 24x | 3x |
| Sun, 15 Oct 2023 | UK£278.4b | UK£86.2b | UK£10.3b | 39.9x | 27.1x | 3.2x |
| Tue, 12 Sep 2023 | UK£271.4b | UK£84.6b | UK£10.2b | 40.2x | 26.6x | 3.2x |
| Thu, 10 Aug 2023 | UK£279.9b | UK£84.0b | UK£10.2b | 43.5x | 27.6x | 3.3x |
| Sat, 08 Jul 2023 | UK£258.1b | UK£82.2b | UK£7.8b | 42.7x | 32.9x | 3.1x |
| Mon, 05 Jun 2023 | UK£286.7b | UK£83.5b | UK£8.0b | 48.4x | 35.9x | 3.4x |
| Wed, 03 May 2023 | UK£292.3b | UK£83.5b | UK£8.0b | 48.4x | 36.7x | 3.5x |
| Fri, 31 Mar 2023 | UK£277.0b | UK£84.5b | UK£6.9b | 44.8x | 40x | 3.3x |
| Sun, 26 Feb 2023 | UK£280.3b | UK£85.9b | UK£7.1b | 43.7x | 39.5x | 3.3x |
| Tue, 24 Jan 2023 | UK£279.5b | UK£94.1b | UK£6.6b | 36x | 42.7x | 3x |
| Thu, 22 Dec 2022 | UK£282.4b | UK£95.3b | UK£6.6b | 36.4x | 42.6x | 3x |
| Sat, 19 Nov 2022 | UK£273.4b | UK£95.8b | UK£6.7b | 32.8x | 41x | 2.9x |
| Mon, 17 Oct 2022 | UK£252.2b | UK£96.5b | UK£4.0b | 27.4x | 63.2x | 2.6x |
| Wed, 14 Sep 2022 | UK£270.5b | UK£94.3b | UK£4.1b | 37.9x | 66.4x | 2.9x |
| Fri, 12 Aug 2022 | UK£270.5b | UK£92.2b | UK£4.1b | 35.8x | 66.7x | 2.9x |
| Sun, 10 Jul 2022 | UK£310.7b | UK£89.9b | UK£4.9b | 34.3x | 63.2x | 3.5x |
| Tue, 07 Jun 2022 | UK£293.2b | UK£88.1b | UK£5.0b | 28.9x | 58.9x | 3.3x |
| Thu, 05 May 2022 | UK£305.0b | UK£88.6b | UK£5.0b | 31.8x | 60.6x | 3.4x |
| Sat, 02 Apr 2022 | UK£296.2b | UK£81.0b | UK£5.1b | 37x | 58x | 3.7x |
| Mon, 28 Feb 2022 | UK£276.3b | UK£80.1b | UK£5.1b | 32.8x | 54.2x | 3.5x |
| Wed, 26 Jan 2022 | UK£271.8b | UK£75.4b | UK£6.0b | 31.9x | 45x | 3.6x |
| Fri, 24 Dec 2021 | UK£283.1b | UK£75.7b | UK£6.1b | 31.5x | 46.7x | 3.7x |
Price to Earnings Ratio
46.7x
Current Industry PE
- Investors are pessimistic on the British Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 32.5x which is lower than its 3-year average PE of 42.5x.
- The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 7.8% per year over the last three years.
- Revenues for these companies have grown 4.1% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare sector?
| GB Market | -1.18% | |
| Healthcare | -2.31% | |
| Life Sciences | 7.96% | |
| Healthcare Services | -0.29% | |
| Medical Equipment | -1.02% | |
| Healthtech | -1.84% | |
| Biotech | -1.91% | |
| Pharma | -2.51% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 92.1x.
- Analysts are expecting annual earnings growth of 22.3%, which is lower than the prior year's growth of 39.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 34% over the next 5 years.
- This is better than its past earnings decline of 40% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 20% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.53 | 3.9% +UK£55.3m | -23.4% | PS8.7x | |
| INDV Indivior | UK£9.31 | 2.5% +UK£29.0m | -18.8% | PS1.3x | |
| REDX Redx Pharma | UK£0.15 | 62.2% +UK£22.4m | -53.8% | PS13.9x | |
| MXCT MaxCyte | UK£3.43 | 5.9% +UK£20.1m | -4.1% | PS10.1x | |
| EMIS EMIS Group | UK£19.20 | 0.1% +UK£16.1m | 2.8% | PE40.4x |
